Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enfu Hui

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cellular & Molecular Immunology|September 19, 2019
TCR-pMHC bond conformation controls TCR ligand discriminationDibyendu K Sasmal, Wei Feng, Sobhan Roy, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Innate extracellular Hsp70 inflammatory properties are mediated by the interaction of Siglec-E and LOX-1 receptorsThiago J Borges, Karina Lima, Ayesha Murshid, et al.
Science Immunology|January 3, 2025
Functional differences between rodent and human PD-1 linked to evolutionary divergenceTakeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Evolutionary fingerprint in rodent PD1 confers weakened activity and enhanced tumor immunity compared to human PD1Takeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Metabolism: Clinical and Experimental|November 15, 2025
Obesity rewires CD8+ T cell iron metabolism in adipose tissue to fuel metabolic inflammationJinfen Dai, Zixuan Zeng, Lishuan Wang, et al.
Cell|July 31, 2020
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell TherapyWei Wu, Qiuping Zhou, Takeya Masubuchi, et al.
Immunity|March 9, 2022
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8<sup>+</sup> T cell responsesKarl L Banta, Xiaozheng Xu, Avantika S Chitre, et al.
Science Translational Medicine|May 7, 2025
The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejectionThiago J Borges, Karina Lima, Rodrigo B Gassen, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cellular & Molecular Immunology|September 19, 2019
TCR-pMHC bond conformation controls TCR ligand discriminationDibyendu K Sasmal, Wei Feng, Sobhan Roy, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Innate extracellular Hsp70 inflammatory properties are mediated by the interaction of Siglec-E and LOX-1 receptorsThiago J Borges, Karina Lima, Ayesha Murshid, et al.
Science Immunology|January 3, 2025
Functional differences between rodent and human PD-1 linked to evolutionary divergenceTakeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Evolutionary fingerprint in rodent PD1 confers weakened activity and enhanced tumor immunity compared to human PD1Takeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Metabolism: Clinical and Experimental|November 15, 2025
Obesity rewires CD8+ T cell iron metabolism in adipose tissue to fuel metabolic inflammationJinfen Dai, Zixuan Zeng, Lishuan Wang, et al.
Cell|July 31, 2020
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell TherapyWei Wu, Qiuping Zhou, Takeya Masubuchi, et al.
Immunity|March 9, 2022
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8<sup>+</sup> T cell responsesKarl L Banta, Xiaozheng Xu, Avantika S Chitre, et al.
Science Translational Medicine|May 7, 2025
The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejectionThiago J Borges, Karina Lima, Rodrigo B Gassen, et al.
Pageof 4